Caris Life Sciences, Inc. (CAI) Stock Overview
Explore Caris Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Caris Life Sciences, Inc. (CAI)
Key Financials
Key Financials
Market Cap
9B
P/E Ratio
86.10
EPS (TTM)
$0.36
ROE
0.19%
CAI Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Caris Life Sciences, Inc. (NASDAQ: CAI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Caris Life Sciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CAI on the NASDAQ shows an RSI of 60.88, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $20.49 for the NASDAQ listing.
Key metrics behind Caris Life Sciences, Inc.'s NASDAQ-traded stock include a P/E ratio of 86.10 and a market capitalization of 9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CAI on the NASDAQ.